Ly6k cancer
WebThe human ortholog of this protein, LY6K, has been characterized to be a cancer testes antigen. It is found to be upregulated in numerous types of cancer, including esophageal … Web1 apr. 2024 · LY6K is a prospective immunotherapy target because it induces immune cell responses in breast cancer [32]. PTHLH promotes poor outcomes and metastasis in …
Ly6k cancer
Did you know?
Web1 sept. 2024 · LY6K promotes glioblastoma tumorigenicity via CAV-1-mediated ERK1/2 signaling enhancement. Coronavirus: Find the latest articles and preprints ... WebRegulation of LY6K expression LY6K is a cancer/testicular antigen that is highly expressed in cancer cells and tissues but is not expressed in normal tissues other than the testis. …
Web18 ian. 2011 · Background: The aim of this study is to find a novel molecular target based on chromosomal alteration and array-based gene expression analyses in bladder cancer … WebThe invasiveness and metastatic function of LY6K in cancer as a diagnostic biomarker and therapeutic target has been elucidated in various cancers such as head and neck …
Web1 sept. 2024 · LY6K is a member of LY6/urokinase-type plasminogen activator receptor family of proteins and has a glycosylphosphatidylinositol (GPI) anchor that results in its … WebThis study sets up the groundwork to discover novel drugs targeting LY6K to treat cancers with high LY6K expression. 2. Results 2.1. LY6K Is a Feasible Target to Develop …
Web21 mar. 2024 · LY6K (Lymphocyte Antigen 6 Family Member K) is a Protein Coding gene. Diseases associated with LY6K include Lung Cancer . Among its related pathways are …
Web24 apr. 2013 · Background Lymphocyte antigen 6 complex locus K (LY6K) has been identified as a tumor-associated antigen in lung cancers and esophageal squamous cell … overly paranoidWeb24 apr. 2013 · Background Lymphocyte antigen 6 complex locus K (LY6K) has been identified as a tumor-associated antigen in lung cancers and esophageal squamous cell carcinomas. The immunogenicity of LY6K-177 peptide vaccine therapy has been demonstrated in patients with advanced esophageal cancer. This study extends this … ramsay health care group uk revenueWeb10 iul. 2024 · A target of esophageal squamous cell carcinoma and lung cancer types is lymphocyte antigen 6 complex locus K (LY6K), which is expressed in gastric cancer . LY6K-177 peptide vaccine emulsified with … ramsay health care jobs chelmsfordWebElevated gene expression of Lymphocyte antigen 6K (LY6K) in cancer cells is associated with poor survival outcomes in multiple different cancer types including cervical, breast, ovarian, lung, and head and neck cancer. Since inhibition of LY6K expression inhibits cancer cell growth, we set out to explore whether pharmacological inhibition of LY6K … overly packed women\u0027s luggageWeb4 oct. 2024 · Lymphocyte antigen 6 family member K (LY6K) is upregulated in a number of types of cancer and promotes tumor cell proliferation and metastasis. In addition, LY6K … ramsay health care joondalup jobsWeb2 oct. 2024 · The increased expression of Ly6K was associated with poor survival in ovarian, colorectal, gastric, breast, lung, bladder, and brain and CNS cancer patients … overly pcWeb17 ian. 2024 · Purpose Esophageal cancer is a common disease in China with low survival rate due to no obvious early symptoms and lack of effective screening strategies. Traditional treatments usually do not produce desirable results in patients with advanced esophageal cancer, so immunotherapy which relies on tumor-related antigens is needed to combat … overly particular